World Health Organization site
Skip Navigation Links

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Last refreshed on: 19 February 2015
Main ID:  NCT00687180
Date of registration: 28/05/2008
Prospective Registration: No
Primary sponsor: Rigshospitalet, Denmark
Public title: Mycophenolate vs Azathioprin in Autoimmune Hepatitis
Scientific title:
Date of first enrolment: January 2005
Target sample size:
Recruitment status: Completed
Study type:  Interventional
Study design:  Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Key inclusion & exclusion criteria

Inclusion Criteria:

- De novo autoimmune hepatitis

- Consent

Exclusion Criteria:

- age below 18

- pregnancy

Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Autoimmune Hepatitis
Drug: Treatment with azathioprin
Drug: Treatment with mycophenolat mofetil
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
MMF vs Imurel
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results available:
Date Posted:
Date Completed:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history